
BICO Group
39,36
SEK
-5,16 %
BICO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Mindre end 1K følgere
-5,16%
+22,54%
+22,92%
+14,82%
-17,9%
-8,68%
-73,6%
-64,6%
+188,88%
BICO Group is active in medical technology. The company specializes in bio convergence and provides technology, products, and services for biology. With a focus on the application areas bioprinting, multi-omics, cell line development, and diagnostics, the company develops and markets technology that enables researchers to grow cells in 3D environments, conduct drug screening, and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries.
Læs mereMarkedsværdi
2,78 mia. SEK
Aktieomsætning
14,96 mio. SEK
Omsætning
1,95 mia.
EBIT %
-14,85 %
P/E
-
Udbytteafkast, %
-
Finanskalender
29.4
2025
Delårsrapport Q1'25
8.5
2025
Generalforsamling '25
19.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper

Publication of BICO Group AB: Year-end report 2024
BICO Group AB (publ) has repurchased convertible bonds to a total nominal amount of SEK 276m
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Invitation to the presentation of BICO’s Year-end report 2024
BICO completes the divestment of Nanoscribe

BICO, Audiocast with teleconference, Q3'24
Publication of BICO Group Interim Report January-September 2024
CELLINK announces further right-sizing and launches sharpened commercial agenda
BICO Group AB (publ) has repurchased convertible bonds to a total nominal amount of SEK 118m
BICO has entered into an agreement to divest Nanoscribe
Invitation to the presentation of BICO’s interim report Q3, 2024
BICO’s Calendar for financial reporting: H2 2024 and 2025
BICO Group AB’s Nomination Committee for the 2025 Annual General Meeting
BICO’ Capital Markets Day 2024: Launch of BICO’s Updated strategy, BICO 2.0

BICO, Capital Markets Day, 2024
